> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Integrated Continuous Glucose Monitor is Class 2
- URL: https://www.fdaweb.com/integrated-continuous-glucose-monitor-is-class-2/
- Published: 2022-02-18T12:00:00.000Z
- Updated: 2026-09-14T17:33:22.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151197

*Federal Register* notice: FDA is classifying the integrated continuous glucose monitoring system into medical device Class 2 (special controls). The action is based on a Dexcom de novo classification request for the Dexcom G6 Continuous Glucose Monitoring System. The agency has identified the device as being intended for use to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-02-18/pdf/2022-03504.pdf?ref=fdaweb.com).